DEVELOPMENTAL NEUROSCIENCES Do We Know Enough to Prevent or Reverse Major Behavioral Disorders? Scientific Program of the NAM Annual Meeting October 16, 2017 Washington, DC Annual Meeting Program Planning Committee Gilbert S. Omenn, MD, PhD (Chair), Professor of Computational Medicine and Bioinformatics, Internal Medicine, Human Genetics, and Public Health, Center for Computational Medicine and Bioinformatics, University of Michigan Nancy E. Adler, PhD, Professor of Medical Psychology, Departments of Psychiatry and Pediatrics and Director, Center for Health and Community, University of California, San Francisco W. Thomas Boyce, MD, Lisa and John Pritzker Distinguished Professor of Pediatrics and Psychiatry, School of Medicine, University of California, San Francisco Elaine Fuchs, PhD, Investigator, Howard Hughes Medical Institute and Laboratory Head of Mammalian Cell Biology and Development, The Rockefeller University Steven E. Hyman, MD, Harvard University Distinguished Service Professor and Director, Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard Carla J. Shatz, PhD, Director, BioX and Professor of Biology and Neurobiology, James H. Clark Center, Stanford University Agenda 6:45–8:00 am Breakfast Tent 8:00–8:40 am President’s Report to the NAM Membership Victor J. Dzau, MD, President, National Academy of Medicine 8:40–9:05 am Presentation of Member and Staff Awards Jane E. Henney, MD, Home Secretary, National Academy of Medicine J. Michael McGinnis, MD, Leonard D. Schaeffer Executive Officer, National Academy of Medicine Developmental Neurosciences: Do We Know Enough to Prevent or Reverse Major Behavioral Disorders? 9:05–9:15 am Welcome and Introduction by the Program Chair Gilbert S. Omenn, MD, PhD, Professor of Computational Medicine and Bioinformatics, Internal Medicine, Human Genetics, and Public Health, Center for Computational Medicine and Bioinformatics, University of Michigan 9:15–9:45 am Keynote Address: Genes, Brains, and Flexible Behaviors— Themes and Variations from Simple Animals and Humans Cori Bargmann, PhD, Torsten N. Wiesel Professor, The Rockefeller University, and President of Science, Chan Zuckerberg Initiative 9:45–10:15 am Break 10:15–11:30 am Brain Plasticity and Its Disorders: Autism Spectrum and Schizophrenias Moderator: Joshua A. Gordon, MD, PhD, Director, National Institute of Mental Health, National Institutes of Health Genetic Basis of Autism Matthew W. State, MD, PhD, Oberndorf Family Distinguished Professor in Psychiatry; Chair, Department of Psychiatry; and Director, Langley Porter Psychiatric Institute, University of California, San Francisco Effects of Early Psychosocial Neglect on Typical and Atypical Brain and Behavioral Development Charles A. Nelson III, PhD, Professor of Pediatrics and Neuroscience, Harvard Medical School; Professor of Education, Harvard University; and Richard David Scott Chair in Pediatric Developmental Medicine Research, Boston Children’s Hospital Genetic Basis of Schizophrenia, Including the Role of Synaptic Pruning During Development and Disease Beth Stevens, PhD, Associate Professor of Neurology, F.M. Kirby Neurobiology Program, Boston Children’s Hospital and Harvard Medical School Early Motor, Cognitive, and Neural Predictors of Schizophrenia Spectrum Disorders (SSDs) Deanna M. Barch, PhD, Professor of Psychological and Brain Sciences and Couch Professor of Psychiatry, Washington University in St. Louis 11:30 am–12:00 pm Introductions and Announcements Class of 2016 NAM Members 2017–2018 Robert Wood Johnson Foundation Health Policy Fellows 2017 NAM/AAN/ANA/ANF Distinguished Nurse Scholar-in- Residence 2017–2018 FDA Tobacco Regulatory Science Fellows 2017–2019 NAM Fellows Victor J. Dzau, MD, President, National Academy of Medicine Presentation of the Rhoda and Bernard Sarnat International Prize in Mental Health Huda Akil, PhD, Gardner Quarton Distinguished University Professor of Neuroscience and Psychiatry and Co-Director, The Molecular & Behavioral Neuroscience Institute, University of Michigan Presentation of the Gustav O. Lienhard Award for Advancement of Health Care Regina M. Benjamin, MD, MBA, NOLA.com/Times Picayune Endowed Chair in Public Health Sciences, Xavier University of Louisiana 12:00–1:30 pm General Luncheon Tent Building Leadership Across Generations for Health and Health Policy Luncheon West Court (by invitation) This luncheon will showcase several NAM activities that engage the rising health and health policy leaders, with a particular focus on our Fellowship programs and the DC Public Health Case Challenge. Attendees will have the opportunity to hear about and discuss NAM’s expanding contributions in this area as well as to network and exchange ideas with other participants. Committee on Human Rights (CHR) Luncheon Lecture Room Dr. Vincent Iacopino, Senior Medical Advisor for Physicians for Human Rights, will discuss his involvement in the investigation of the health consequences of human rights abuses worldwide. Dr. Iacopino will also discuss his work as the principal organizer of an international effort to develop UN guidelines on effective documentation of torture and ill treatment (the Istanbul Protocol). NAM members will be provided with an update on the previous day’s meeting of the NAM Interest Group on Human Rights, Professional Ethics, and the Values of Medicine. Estate/Financial Planning Luncheon Board Room Join us for a lunch seminar to learn about timely tax and financial planning opportunities to Provide and Protect your wealth for the people and the causes that you care about. 1:30–2:45 pm Vulnerability and Resilience: Mood and Anxiety Disorders Moderator: Huda Akil, PhD, Gardner Quarton Distinguished University Professor of Neuroscience and Psychiatry and Co-Director, The Molecular & Behavioral Neuroscience Institute, University of Michigan From Pathophysiology to Treatment John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Chair, Department of Psychiatry, Yale University School of Medicine Adolescent Brain Development: Risk and Resilience Beatriz Luna, PhD, Staunton Professor of Psychiatry and Pediatrics and Professor of Psychology, Laboratory of Neurocognitive Development, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center The Neurocircuitry of Vulnerability and Resilience Kafui Dzirasa, MD, PhD, Assistant Professor, Laboratory for Psy- chiatric Neuroengineering and Principal Investigator, Depart- ment of Psychiatry and Behavioral Sciences, Center for Neuro- engineering, Duke University Medical Center The Genetics of Bipolar Disorder Thomas Lehner, PhD, MPH, Director, Office of Genomics Research Coordination, National Institutes of Health 2:45–4:00 pm Reward Mechanisms, Risk-Taking Behavior, and Drivers of Addiction Moderator: Margaret A. Hamburg, MD, Foreign Secretary, National Academy of Medicine Epidemiological Overview of the U.S. Opioid Epidemic and Past Drug Crises Christopher M. Jones, PharmD, MPH, Acting Associate Deputy Assistant Secretary (Science and Data Policy), Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health & Human Services The Biology of Addiction and Reward Circuitry Nora D. Volkow, MD, Director, National Institute on Drug Abuse, National Institutes of Health How Brain and Behavioral Development from Childhood to Adolescence Influence Risky Decision-Making and Susceptibility to Addiction Valerie F. Reyna PhD, Director, Human Neuroscience Institute and Co-Director, Center for Behavioral Economics and Decision Research, Cornell Magnetic Resonance Imaging Facility, Cornell University The Opioid Epidemic: How What We Already Know Can Help Us Howard B. Gutstein, MD, Professor, Department of Anesthesiology, University of Pittsburgh 4:00–4:15 pm Concluding Remarks by the Program Chair Gilbert S. Omenn, MD, PhD, Professor of Computational Medicine and Bioinformatics, Internal Medicine, Human Genetics, and Public Health, Center for Computational Medicine and Bioinformatics, University of Michigan 4:15–5:45 pm The President’s Forum: The U.S. Opioid Epidemic Victor J. Dzau, MD, President, National Academy of Medicine VADM Jerome M. Adams, MD, MPH, U.S. Surgeon General, U.S. Department of Health & Human Services The Honorable Charles D. Baker, Governor of Massachusetts The Honorable Scott Gottlieb, MD, Commissioner, U.S. Food and Drug Administration The Honorable Judge Steve Leifman, JD, Associate Administrative Judge, Miami-Dade County Court The Honorable Kathleen Sebelius, MPA, Co-Chair, Aspen Health Strategy Group and President and CEO, Sebelius Resources Inc. 5:45–5:50 pm Closing Remarks Victor J. Dzau, MD, President, National Academy of Medicine 5:50 pm Adjourn and Reception Great Hall Speakers’ Biosketches VADM Jerome Adams, MD, MPH, the 20th Surgeon General of the United States, was sworn into office by Vice President Mike Pence on September 5, 2017. Dr. Adams, a board-certified anesthesiologist, served as Indiana State Health Commissioner from 2014 to 2017. Dr. Adams, a Maryland native, has bachelor’s degrees in both biochemistry and psychology from the University of Maryland, Baltimore County, a master of public health degree from the University of California at Berkeley, and a medical degree from Indiana University School of Medicine. Dr. Adams was also an associate professor of clinical anesthesia at Indiana University School of Medicine and a staff anesthesiologist at Eskenazi Health, where he was Chair of the Pharmacy and Therapeutics Committee. He has served in leadership